Mawer Investment Management Ltd. Charles River Laboratories International, Inc. Transaction History
Mawer Investment Management Ltd.
- $21.4 Billion
- Q3 2024
A detailed history of Mawer Investment Management Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mawer Investment Management Ltd. holds 40,860 shares of CRL stock, worth $6.68 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
40,860
Previous 73,553
44.45%
Holding current value
$6.68 Million
Previous $15.2 Million
47.03%
% of portfolio
0.04%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$997 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$832 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$612 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$348 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$317 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.32B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...